Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibiotics.
about
Amikacin: a rapid and sensitive radioimmunoassay.Activity of three aminoglycosides and two penicillins against four species of gram-negative bacilliActivity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.Amikacin and cephalothin: empiric regimen for granulocytopenic cancer patients.Resistance of Pseudomonas aeruginosa to gentamicin and related aminoglycoside antibiotics.Transferrable resistance to tobramycin in Klebsiella pneumoniae and Enterobacter cloacae associated with enzymatic acetylation of tobramycin.Effects of gestational age, birth weight, and hypoxemia on pharmacokinetics of amikacin in serum of infants.Antibacterial activities, nephrotoxicity, and ototoxicity of a new aminoglycoside, Win 42122-2.Development of new antituberculosis drugs from natural products.In vitro study of netilmicin compared with other aminoglycosides.Global and effective synergism of amikacin, gentamicin or tobramycin when combined with carbenicillin against Pseudomonas aeruginosa.Antibiotic resistance in Providencia stuartii isolated in hospitals.In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin.Outbreak of multiply drug-resistant Proteus mirabilis originating in a surgical intensive care unit: in vitro susceptibility pattern.In vitro studies with Sch 21420 and Sch 22591: activity in comparison with six other aminoglycosides and synergy with penicillin against enterococci.UK-18,892: resistance to modification by aminoglycoside-inactivating enzymes.In vitro activity, synergism, and testing parameters of amikacin, with comparisons to other aminoglycoside antibiotics.Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic.In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens.Comparison of in vitro antibacterial activities of gentamicin and verdamicin.Phosphorylation of kanamycin, lividomycin A, amd butirosin B by Providencia stuartii.Factors associated with nephrotoxicity and clinical outcome in patients receiving amikacin.Evaluation of three antibiotic programs in newborn infants.[Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].In vitro antibacterial activity of amikacin, a new aminoglycoside, against clinical bacterial isolates from children.Amikacin (BBK8) in infections due to gram-negative organisms in children over the age of one month.Amikacin: Uses, Resistance, and Prospects for Inhibition.Pharmacokinetics of single-dose intravenous amikacin in critically ill patients undergoing slow hemodialysis.Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.
P2860
Q34913978-A62D3B12-8F82-45F7-A65F-0C21F40578E2Q34917476-44A8C1DF-E19B-43B8-9228-232BCD6F47C4Q34979815-1EF6F334-9B64-4003-9C2E-6E8C5812E635Q34988087-001F9B5C-D13C-4E76-A998-D63DEB040FF7Q35656393-84EF279F-F7C9-41CC-BB75-6B44A05B3B3EQ35658162-F37AC4BE-734B-4267-9A73-3A6E94D9BBDFQ36463807-7E6E90E6-F8F7-4A25-A75E-7D3D75BF846FQ36486762-FE90D27F-A2B6-4A79-82FC-F44AD95F9C1FQ39019430-4CBADFC0-7B6B-4C3F-A8A4-87AE860A58FCQ39120437-3812DFC3-A6B8-4781-AB75-634434BBBB8AQ39693899-6A1ECBAB-D06B-444E-B507-CA6659D0EAF0Q40232878-5FD6B89A-4F10-4876-9043-7992F2B021E0Q40616583-F7AF53F3-F265-4A88-B0B5-26A26CE4C863Q40617952-30E3CE67-2765-4FAC-BDDD-98BFE4E2F55EQ40618931-21A56800-5F4F-42A6-A961-E817B1668669Q40619618-F38F7AD4-FAFB-4F60-AA94-9EA2B87886CFQ40946097-F60D97DB-85D2-45BA-80D6-A5E1C55C9ADDQ40947687-02B51B96-0A94-4975-8983-3DBD988AC677Q40947769-6BD3E744-40CF-4D2E-99DD-9F4B39BB9C95Q41030754-5F46C079-721C-422E-A38A-4C1F9E49373CQ41031135-8E955990-AA27-4170-8101-FDAC71CB46EFQ42226724-3DF995D8-5B3C-497D-A624-9DFD3E99C7E9Q42928896-91066FFE-6370-43D4-9CEA-33177B167D7DQ43497084-4DA792FE-9D69-4445-967C-06B6EF51EE12Q43590856-A8188E12-FEC8-4F7A-A984-2A29442119B6Q50228052-D9112C4E-CD58-4349-88FD-C0F4ACC5B111Q52744431-82B971F8-B2DD-4720-B7CE-DA712AAC1605Q54012096-FDDDFACE-6CC2-49E4-B959-9D052FF00F12Q54634286-6C508DBA-9F9C-4D17-89BA-75990263EC0D
P2860
Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibiotics.
description
1974 nî lūn-bûn
@nan
1974年の論文
@ja
1974年論文
@yue
1974年論文
@zh-hant
1974年論文
@zh-hk
1974年論文
@zh-mo
1974年論文
@zh-tw
1974年论文
@wuu
1974年论文
@zh
1974年论文
@zh-cn
name
Activity of BB-K8 (amikacin) a ...... re aminoglycoside antibiotics.
@en
type
label
Activity of BB-K8 (amikacin) a ...... re aminoglycoside antibiotics.
@en
prefLabel
Activity of BB-K8 (amikacin) a ...... re aminoglycoside antibiotics.
@en
P2093
P2860
P356
P1476
Activity of BB-K8 (amikacin) a ...... re aminoglycoside antibiotics.
@en
P2093
P2860
P304
P356
10.1128/AAC.5.2.143
P407
P577
1974-02-01T00:00:00Z